Stephen Shigeo Yano, MD | |
99-128 Aiea Heights Dr, #211, Aiea, HI 96701-3925 | |
(808) 488-8441 | |
(808) 487-2003 |
Full Name | Stephen Shigeo Yano |
---|---|
Gender | Male |
Speciality | Pediatrics |
Location | 99-128 Aiea Heights Dr, Aiea, Hawaii |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043256530 | NPI | - | NPPES |
00909601 | Medicaid | HI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 4377 (Hawaii) | Primary |
Mailing Address | Practice Location Address |
---|---|
Stephen Shigeo Yano, MD 99-128 Aiea Heights Dr, #211, Aiea, HI 96701-3925 Ph: (808) 488-8441 | Stephen Shigeo Yano, MD 99-128 Aiea Heights Dr, #211, Aiea, HI 96701-3925 Ph: (808) 488-8441 |
News Archive
Researchers from the University of Sheffield have discovered valuable insight into how people develop B-cell lymphoma, one of the most common cancers in the UK.
The FDA has granted Cytori Therapeutics 510(k) marketing clearance for its PureGraft™ System. Cytori will now launch the first and only device in the United States cleared for aesthetic body contouring using autologous fat. PureGraft™ allows a patient's own fat tissue to rapidly be prepared in approximately 15 minutes for re-injection back into the same patient for aesthetic contouring.
Children with brain injuries have difficulty developing story-telling skills even though other language abilities, such as vocabulary, tend to catch up with other children as they mature, research at the University of Chicago shows. Our findings suggest that there may be limitations to the remarkable flexibility for language functions displayed by children with brain injuries.
Protalix BioTherapeutics, Inc., announced today it has submitted validation data regarding the Company's manufacturing process for taliglucerase alfa to the U.S. Food and Drug Administration (FDA). The Company made the submission in response to a request from the FDA for validation data from the Company's upgraded manufacturing facility. The FDA is currently reviewing the Company's New Drug Application (NDA) for taliglucerase alfa for the treatment of Gaucher disease.
› Verified 5 days ago
Dr. Kenn Saruwatari, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 98-151 Pali Momi St, Suite 142, Aiea, HI 96701 Phone: 808-483-6400 Fax: 808-483-6082 | |
Yoshio Futatsugi, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 99-128 Aiea Heights Dr, Suite 108, Aiea, HI 96701 Phone: 808-488-6846 | |
Dr. Brent Koichi Tamamoto, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 99-080 Kauhale St, Suite C-22, Aiea, HI 96701 Phone: 808-487-1600 Fax: 808-487-1601 | |
Dr. Vanessa Hisa Fidele, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 98 211 Pali Momi St, Suite 618, Aiea, HI 96701 Phone: 808-486-7799 | |
Brandon D Young, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 99-128 Aiea Heights Dr, Ste 211, Aiea, HI 96701 Phone: 808-488-8441 Fax: 808-200-3790 | |
Dr. Vernon M Azuma, MD,FAAP Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 99-128 Aiea Heights Dr, Suite 211, Aiea, HI 96701 Phone: 808-488-8441 |